Foresight

Foresight Pharma

FORESIGHT PHARMA SDN BHD

The ever-growing pharmaceutical market has prompted Foresight Industries Sdn Bhd (FISB) into establishing a subsidiary, Foresight Pharma Sdn Bhd (FPSB), in October 2017 to serve as its special purpose vehicle into the pharmaceutical trading industry. FPSB used to focus mainly on hemodialysis treatment-related medicines started with erythropoietin (EPO) by being the first drug to enter the market.
image-08
image-09
image-10
image-13
image-11
image-12

We distribute general pharmaceutical drugs and medicines directly to end-users including some of which are used in hemodialysis services, such as erythropoietin (EPO), heparin, sodium, iron sucrose, liquid paraffin as well as scheduled and non-scheduled poison.

Moving forward for FPSB is to become a big player in drug distribution and wholesale activity. By being a distributor and wholesaler of generic drugs, FPSB need to aggressively compete with current generic drugs in the market which have a competitive price.

Other subsidiaries

Other Subsidiaries FISB 2

Foresight Industries

Other Subsidiaries FDSB

FORESIGHT DIALYSIS

Other Subsidiaries FMSB

FORESIGHT MEDITECH

Scroll to Top